People · Operator
Named in public records as an officer, director or promoter · active 2022–2026 · Pharmaceuticals, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Altesa BioSciences, Inc. | — | Pharmaceuticals | Series C | $110.0M | $373.9M | 2022 |
| Novella, Inc. | — | Other Technology | Pre-Seed | $300K | $4.4M | 2022 |
Nicholas Williams at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Nicholas Williams on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ittai Harel | 1 | 6 |
| Seth Rudnick | 1 | 5 |
| Moncef Slaoui | 1 | 3 |
| Brett Giroir | 1 | 3 |
| Matthew Sayovitz | 1 | 1 |
| Eric Simons | 1 | 1 |
| John Clerici | 1 | 1 |
| Andrew Drechsler | 1 | 1 |
| Jon Edwards | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.